Oxxon Therapeutics
Latest round
- Series A
Last raised
- Nov 2000
Total raised
- $7.7M
Investors
- 1
About Oxxon Therapeutics
Oxxon Therapeutics Ltd is a biopharmaceutical company developing innovative antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer.
Who invested in Oxxon Therapeutics
1 investor across 1 round
See all investors in Oxxon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 1, 2000
Amount
$7.7M
Investors
Questions about Oxxon Therapeutics
Who invested in Oxxon Therapeutics?
Oxxon Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oxxon Therapeutics raised?
Oxxon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oxxon Therapeutics last raise money?
Oxxon Therapeutics's most recent round on record is a Series A, in Nov 2000.
What does Oxxon Therapeutics do?
Oxxon Therapeutics Ltd is a biopharmaceutical company developing innovative antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer.
Where is Oxxon Therapeutics headquartered?
Oxxon Therapeutics is headquartered in Oxford, UK.
Which VCs invest in companies like Oxxon Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Oxxon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Oxxon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.